However, future studies of circulating basophils in cancer may benefit from the inclusion of additional markers for basophil identification (such as CD203c, CD123, and CRTH2), and basophil activation (such as CD203c, CD107a, CD13, CD164, CD69, and histamine or tryptase release) [9,42]. This evidence concerns the gene CD164 and cancer.